InsiderTrades

Form 4 for CVS CVS Health

Accepted 2022-04-05 00:00:00 ET · period of report 2022-04-01 · accession 0001127602-22-011609 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-04-05 2022-04-01 CVS Clark James David SVP, Cont, Chief Acct Off A - Grant $101.09 +3,214 12.8K +33% +$324.9K
DM 2022-04-05 2022-04-01 CVS Clark James David SVP, Cont, Chief Acct Off F - Tax $101.09 -6,637 29.1K -19% -$670.9K
D 2022-04-05 2022-04-01 CVS Clark James David SVP, Cont, Chief Acct Off A - Grant $101.09 +6,756 6,756 New +$683.0K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock (restricted) 2022-04-01 A A 3,214 $101.09 12,824 D — —
2 Common Common Stock 2022-04-01 F D 2,740 $101.09 26,330.26 D — — (F2) Surrrender of shares in payment of withholding taxes due upon the vesting of restricted stock awards.
3 Common Common Stock 2022-04-01 F D 3,897 $101.09 29,070.26 D — — (F1) Surrender of shares in payment of withholding taxes due upon the vesting and settlement of the PSUs.
4 Derivative Stock Option 2022-04-01 A A 6,756 $101.09 6,756 D $101.09 · 2023-04-01 to 2032-04-01 6,756 Common Stock (F3) Option becomes exercisable in four equal installments, commencing 4/1/2023.